VTGN
Vistagen Therapeutics, Inc. Common Stock
stockNASDAQ
Market OpenNov 10, 2026 11:39:19 AM EST
0.18USD-2.603%(-0.00)313,509
Pre-marketNov 10, 2026 9:27:30 AM EST
0.1879USD+1.898%(+0.0035)
VTGN Financials
In Q1 FY 2027 (ended ), Vistagen Therapeutics, Inc. Common Stock (VTGN) reported revenue of $1.48M, net income of −$13.03M, operating cash flow of −$14.71M, and assets of $35.74M (filed ).
Loading financial statements…